Sofosbuvir Cost-Effective for Hepatitis C Genotype 2 or 3? Only in Certain Patients (FREE)

By Amy Orciari Herman Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH Sofosbuvir-based therapy is cost-effective in patients with hepatitis C genotype 2 or 3 infection plus cirrhosis and in those who've previously been treated with interferon, according to a simulation study …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news